Cargando…
Incorporating Molecular Tools into Early-Stage Clinical Trials
The author discusses the implications of a new phase I trial investigating the role of rapamycin in patients with glioblastoma.
Autor principal: | Weil, Robert J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211557/ https://www.ncbi.nlm.nih.gov/pubmed/18215108 http://dx.doi.org/10.1371/journal.pmed.0050021 |
Ejemplares similares
-
Targeted Next-Generation Sequencing Analysis for Recurrence in Early-Stage Lung Adenocarcinoma
por: Kim, In Ae, et al.
Publicado: (2020) -
Numerical and functional defects of blood dendritic cells in early- and late-stage breast cancer
por: Pinzon-Charry, A, et al.
Publicado: (2007) -
Data Safety and Monitoring Boards Should Be Required for Both Early- and Late-Phase Clinical Trials
por: Van Norman, Gail A.
Publicado: (2021) -
Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats
por: Uchino, H, et al.
Publicado: (2005) -
Tools for Assessing Neuropathic Pain
por: Cruccu, Giorgio, et al.
Publicado: (2009)